CN105435135A - 一种治疗肾结石的中药制剂及其制备方法 - Google Patents
一种治疗肾结石的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN105435135A CN105435135A CN201610052829.5A CN201610052829A CN105435135A CN 105435135 A CN105435135 A CN 105435135A CN 201610052829 A CN201610052829 A CN 201610052829A CN 105435135 A CN105435135 A CN 105435135A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine preparation
- preparation
- treatment
- hour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 71
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 208000000913 Kidney Calculi Diseases 0.000 title claims abstract description 29
- 235000021419 vinegar Nutrition 0.000 claims abstract description 18
- 239000000052 vinegar Substances 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 210000003038 endothelium Anatomy 0.000 claims abstract description 12
- 229910052623 talc Inorganic materials 0.000 claims abstract description 7
- 239000000454 talc Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 206010029148 Nephrolithiasis Diseases 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 14
- 241000972673 Phellodendron amurense Species 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 7
- 235000012222 talc Nutrition 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 235000019640 taste Nutrition 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 26
- 230000027939 micturition Effects 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 230000001737 promoting effect Effects 0.000 abstract description 15
- 208000024891 symptom Diseases 0.000 abstract description 6
- 208000008035 Back Pain Diseases 0.000 abstract description 5
- 208000008930 Low Back Pain Diseases 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 235000008216 herbs Nutrition 0.000 abstract description 4
- 230000003907 kidney function Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000009825 accumulation Methods 0.000 abstract description 3
- 241000722953 Akebia Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000025505 Pyrrosia Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 235000019996 baijiu Nutrition 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 206010013990 dysuria Diseases 0.000 abstract 1
- 230000023597 hemostasis Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 18
- 230000036407 pain Effects 0.000 description 17
- 208000004880 Polyuria Diseases 0.000 description 13
- 230000035619 diuresis Effects 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 11
- 208000006750 hematuria Diseases 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 210000003932 urinary bladder Anatomy 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000001848 dysentery Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000002485 urinary effect Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000009911 Urinary Calculi Diseases 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 210000001624 hip Anatomy 0.000 description 3
- 201000008383 nephritis Diseases 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- CPGCVOVWHCWVTP-LJAQVGFWSA-N (S)-nonacosan-10-ol Chemical compound CCCCCCCCCCCCCCCCCCC[C@@H](O)CCCCCCCCC CPGCVOVWHCWVTP-LJAQVGFWSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 206010009168 Chyluria Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038419 Renal colic Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- CPGCVOVWHCWVTP-UHFFFAOYSA-N celidoniol Natural products CCCCCCCCCCCCCCCCCCCC(O)CCCCCCCCC CPGCVOVWHCWVTP-UHFFFAOYSA-N 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 210000004317 gizzard Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- 210000000244 kidney pelvis Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001452 natriuretic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种治疗肾结石的中药制剂及其制备方法,涉及中药领域。所述中药制剂有效成分的原料组成:金银花、连翘、黄柏、金钱草、石韦、海金沙、鱼腥草、鸡内金、木通、瞿麦、萹蓄、郁金、枳壳、滑石、甘草;所述药物分别用白酒陈醋浸提,使药物有效成分充分溶出,再浓缩至相对密度1.05-1.20的溶液与食用陈醋混合。本发明所述制剂具有活血化瘀、清热利水、排石消积之功效,对肾脏排石疗效显著,对结石引起的腰痛、血尿、尿频、尿急、尿痛等泌尿梗阻和感染有良好治疗效果,并通过凉血破瘀、止血生肌恢复肾脏功能,安全无毒副作用,作为外敷药,有效成分吸收多、疗程短、疗效明显,对肾脏结石的治疗有重大临床意义,值得广泛推广应用。
Description
【技术领域】
本发明涉及中药技术领域,具体涉及一种治疗肾结石的中药制剂以及该中药制剂的制备方法。
【背景技术】
肾结石是一种常见的多发病,肾结石主要包括颗粒型结石和泥沙型结石,多数位于肾盂肾盏内,肾实质结石少见。中医将其归属为淋证,为湿热蕴结并气虚血瘀证,有典型突然发作的肾绞痛,伴肉眼或镜下血尿;或仅有腰腹部钝痛,酸胀不适,或有排石史;严重的影响人们的身体健康,其发病多与代谢、饮食、环境以及泌尿疾病等多种因素有关。
目前治疗肾结石以解痉止痛,去除结石,维持肾功能及预防复发为原则,以结石大小、部位、数目、并发症与全身情况酌情进行手术、非手术及时特殊治疗,由于手术治疗费用高,而且麻烦,患者也痛苦,现在90%以上都不采用手术治疗,而是非手术治疗,其中中药治疗是最常见的,如:排石饮液、排石冲剂、石淋通、化石散、消石素及其他相关中草药等,但由于种种原因,现在的治疗肾结石的药物都为内服,其存在有效物达到病灶的量少,起效慢、疗效不理想、疗程长、易复发等问题。
【发明内容】
本发明的目的在于:针对上述存在的问题,提供了一种治疗肾结石的中药制剂及制备方法,本发明的中药制剂通过十五种药物合理配伍,具有活血化瘀、清热利水、排石消积之功效,对于肾脏排石具有显著疗效,对于结石引起的腰痛、血尿、尿频、尿急、尿痛等泌尿系统梗阻和感染具有良好的治疗效果,并通过凉血破瘀、止血生肌恢复肾脏功能,安全无毒副作用,作为外敷药,有效成分吸收多、疗程短、疗效明显,对于肾脏结石的治疗具有重大的临床意义,值得广泛推广应用。
为了实现上述目的,本发明采用的技术方案如下:
一种治疗肾结石的中药制剂,该中药制剂包括如下重量份的原料:
进一步地,该中药制剂包括如下重量份的原料:
进一步地,该中药制剂包括如下重量份的原料:
本发明还提供上述中药制剂的制备方法,包括以下步骤:
(1)按重量份称取各种原料药;
(2)将黄柏、郁金、枳壳、甘草和木通一起切成2-5mm大小的碎粒,然后倒入50%vol白酒浸泡1-3小时,白酒的量以浸没倒入的药物为准,然后用水回流,每次加上以上所有药物重量2-5倍的水加热回流提取2-3次,每次提取1-3小时,过滤,合并滤液;
(3)取鸡内金研磨成粉末,金银花、连翘、金钱草、石韦、海金沙、鱼腥草、瞿麦和萹蓄切碎为长度小于1cm的颗粒,加入8-10倍量的食用陈醋溶液浸泡0.5-3小时,陈醋溶液为食用醋和纯净水按体积比1:1混合,用水回流,每次加上以上9味药重量2-5倍的水加热回流提取2-3次,每次提取1-3小时,过滤,合并滤液;
(4)将步骤(2)和步骤(3)中的滤液混合在一起再加入滑石,搅拌混匀,加热煮沸保持10-30分钟,过滤,滤液冷却至30-50℃,浓缩至室温测定相对密度为1.05-1.20的溶液,然后按照体积比1:1加入食用陈醋混合得到最终制剂。
进一步地,所述黄柏的制作方法为:取质量比为生黄柏1/10的食盐,用开水化开,然后放进生黄柏,食盐水量以浸没生黄柏为准,浸泡0.5-2个小时,然后全部倒入干净的铁锅,待盐水蒸干后,用文火慢慢翻炒约10-15分钟,至颜色表面发黑,得到步骤(2)中所用黄柏。
进一步地,所述鸡内金的制作方法为:将称量好的鸡内金放入温度为60-80℃烘箱中烘烤8-10小时,在冷冻干燥气体下冷至室温,粉碎为过50-100目筛的粉末。
本发明的各种原料的具体功效如下:
金银花:味甘,性寒,归肺,胃,心,大肠经。主要含绿原酸、异绿原酸、白果醇等,具有清热解毒、疏散风热、疏利咽喉、消暑除烦的作用。可治疗暑热症、泻痢、流感、疮疖肿毒、急慢性扁桃体炎、牙周炎等病。
连翘:味苦,性微寒。归肺、心、胆经。连翘有广谱抗菌作用,对金黄色葡萄球菌、贺氏痢疾杆菌有很强的抑制作用,对其他致病菌、流感病毒、真菌都有一定抑制作用,有抗炎作用。本品所含齐墩果酸有强心、利尿及降血压作用,维生素P可降低血管通透性及脆性,防止溶血。煎剂有镇吐、抗肝损伤作用,且清热解毒,消肿散结,疏散风热。主治痈肿疮毒,痰核瘰疬,外感风热,温病初起,热淋涩痛等。
黄柏:味苦,性寒。归肾经、膀胱、大肠经。具有清热、燥湿、泻火、解毒,治热痢、泄泻、消渴、黄疸、痿躄、梦遗、淋浊、痔疮、便血、亦白带下、骨蒸劳热、目赤肿痛、口舌生疮、疮疡肿毒等疾病。黄柏入肾,肾苦燥停湿,柏味微辛而能润燥,性利下而能除湿,故为肾经主药。
金钱草:味甘、微苦,性寒。归肝、胆、肾、膀胱经。有清热利尿、祛风止痛、止血生肌、消炎解毒、杀虫之功效。可治疗急慢性肝炎、黄疸型肝炎、胆囊炎、肾炎、泌尿系感染、扁桃腺炎、口腔炎及痈疔疗毒、毒蛇咬伤、乳痈、痢疾、疟疾、肺出血等。
石韦:苦甘,性寒,入肺、膀胱经。《本经》记载:石苇主劳热邪气,五癃闭不通,利小便水道。利水通淋,清肺泄热。治淋痛、尿血、尿路结石、肾炎、崩漏、痢疾、肺热咳嗽、慢性气管炎、金疮、痈疽等。
海金沙:味甘,性寒。归膀胱、小肠经。有清热解毒,利水通淋。可治疗尿路感染、尿路结石、白浊、白带、肝炎、肾炎水肿、咽喉肿痛、痄腮、肠炎、痢疾、皮肤湿疹、带状疱疹。《纲目》记载:海金沙治湿热肿满、小便热淋、膏淋、血淋、石淋、茎痛、解热毒气。《江西草药》记载:海金沙具有清热解毒、利尿除湿,可治疗肝炎、肾性水肿、皮肤湿疹、水痘、尿血、痄腮、风火牙痛、喉蛾、白喉、带状疱疹、小儿疳积等疾病。
鱼腥草:味辛,性寒。归肺经。能清热解毒、消肿疗疮、利尿除湿、清热止痢、健胃消食,用治实热、热毒、湿邪、疾热为患的肺痈、疮疡肿毒、痔疮便血、脾胃积热等。现代药理实验表明:鱼腥草具有抗菌、抗病毒、提高机体免疫力、利尿等作用,用鱼腥草提取物能使毛细血管扩张,增加血流量及尿液分泌,从而具有利尿的作用。
鸡内金:味甘,性寒。归脾、胃、小肠、膀胱经。《本草经疏》记载:肫是鸡之脾,乃消化水谷之所,其气通达大肠、膀胱二经,有热则泄痢遗溺,得微寒之气则热除,而泄痢遗溺自愈矣,烦因热而生,热去故烦自止也。今世又以之治诸疳疮、化积排石、固摄缩尿等作用。
木通:味苦,性寒。归心经、小肠经、膀胱经。是利水化湿中药,主治胸中烦热、喉痹咽痛、尿赤、五淋、水肿、周身挛痛、经闭、乳少。
瞿麦:味苦,性寒。归经:入心、肾、小肠、膀胱经。全草入药,有清热、利尿、破血通经功效。治小便不通、淋病、水肿、经闭、痈肿、目赤障翳、浸淫疮毒等症状。
萹蓄:味苦,性寒。归膀胱经。主治热淋、癃闭、黄疸、阴蚀、白带、蛔虫、疳积、痔肿、湿疮。
郁金:味辛、苦,性寒,无毒。《唐本草》记载:郁金具有行气解郁,凉血破瘀的功效。治胸腹胁肋诸痛、失心癫狂、热病神昏、吐血、衄血、尿血、血淋、妇女倒经、黄疸。
枳壳:味苦、辛、酸、温,具有理气宽中、行滞消胀的功效,主治胸胁气滞、胀满疼痛、食积不化、痰饮内停、胃下垂、脱肛、子官脱垂等病症,枳壳增加冠脉流量和肾血流血,有明显增加尿量的作用,同时血压与肾血管阻力明显增高。其利尿作用可能是通过抑制肾小管重吸收等其他作用而产生。另有研究认为枳实通过强行收缩肾血管,增高滤过压而发挥排钠利尿作用。
滑石:味甘、淡,性寒。归膀胱、肺、胃经。《本草衍义补遗》记载:滑石燥湿、分水道、实大肠、化食毒、行积滞、逐凝血、解燥渴、补脾胃、降心火之要药。
综上所述,由于采用了上述技术方案,本发明的有益效果是:
(1)本发明的中药制剂通过十五种药物合理配伍,具有活血化瘀、清热利水、排石消积之功效,对于肾脏排石具有显著疗效,对于结石引起的腰痛、血尿、尿频、尿急、尿痛等泌尿系统梗阻和感染具有良好的治疗效果,并通过凉血破瘀、止血生肌恢复肾脏功能。
(2)本发明中药制剂为外敷中药,安全无毒副作用,且药物通过皮肤渗透直达病灶,有效成分吸收多、疗程短、疗效明显,对于肾结石的治疗具有重大的临床意义,值得广泛推广应用。
【具体实施方式】
以下通过具体实施例和临床资料对本发明作进一步详述。
一、配方实施例
实施例1
一种治疗肾结石的中药制剂,包括如下重量份的原料:
实施例2
一种治疗肾结石的中药制剂,包括如下重量份的原料:
实施例3
一种治疗肾结石的中药制剂,包括如下重量份的原料:
实施例4
一种治疗肾结石的中药制剂,包括如下重量份的原料:
实施例5
一种治疗肾结石的中药制剂,包括如下重量份的原料:
二、制备实施例
实施例6
制备上述实施例1-5的中药制剂的方法可以按照以下步骤进行:
(1)按重量份称取各种原料药;
(2)先取质量比为生黄柏1/10的食盐,用开水化开,然后放进生黄柏,食盐水量以浸没生黄柏为准,浸泡0.5小时,然后全部倒入干净的铁锅,待盐水蒸干后,用文火慢慢翻炒约10分钟,至颜色表面发黑,得到黄柏;
(3)将称量好的鸡内金放入温度为60℃烘箱中烘烤10小时,在冷冻干燥气体下冷至室温,粉碎为过50目筛的粉末;
(4)将黄柏、郁金、枳壳、甘草和木通一起切成2-5mm大小的碎粒,然后倒入50%vol白酒浸泡1小时,白酒的量以浸没倒入的药物为准,然后用水回流,每次加上以上所有药物重量2倍的水加热回流提取2次,每次提取1小时,过滤,合并滤液;
(5)取鸡内金研磨成粉末,金银花、连翘、金钱草、石韦、海金沙、鱼腥草、瞿麦和萹蓄切碎为长度小于1cm的颗粒,加入8倍量的食用陈醋溶液浸泡0.5小时,陈醋溶液为食用醋和纯净水按体积比1:1混合,用水回流,每次加上以上9味药重量2倍的水加热回流提取2次,每次提取1小时,过滤,合并滤液;
(6)将步骤(4)和步骤(5)中的滤液混合在一起再加入滑石,搅拌混匀,加热煮沸保持10分钟,过滤,滤液冷却至30℃,浓缩至室温测定相对密度为1.05的溶液,然后按照体积比1:1加入食用陈醋混合得到最终制剂。
实施例7
制备上述实施例1-5的中药制剂的方法可以按照以下步骤进行:
(1)按重量份称取各种原料药;
(2)先取质量比为生黄柏1/10的食盐,用开水化开,然后放进生黄柏,食盐水量以浸没生黄柏为准,浸泡3小时,然后全部倒入干净的铁锅,待盐水蒸干后,用文火慢慢翻炒约15分钟,至颜色表面发黑,得到盐黄柏;
(3)将称量好的鸡内金放入温度为80℃烘箱中烘烤8小时,在冷冻干燥气体下冷至室温,粉碎为过100目筛的粉末;
(4)将黄柏、郁金、枳壳、甘草和木通一起切成2-5mm大小的碎粒,然后倒入50%vol白酒浸泡3小时,白酒的量以浸没倒入的药物为准,然后用水回流,每次加上以上所有药物重量5倍的水加热回流提取3次,每次提取3小时,过滤,合并滤液;
(5)取鸡内金研磨成粉末,金银花、连翘、金钱草、石韦、海金沙、鱼腥草、瞿麦和萹蓄切碎为长度小于1cm的颗粒,加入10倍量的食用陈醋溶液浸泡3小时,陈醋溶液为食用醋和纯净水按体积比1:1混合,用水回流,每次加上以上9味药重量5倍的水加热回流提取3次,每次提取3小时,过滤,合并滤液;
(6)将步骤(4)和步骤(5)中的滤液混合在一起再加入滑石,搅拌混匀,加热煮沸保持30分钟,过滤,滤液冷却至50℃,浓缩至室温测定相对密度为1.20的溶液,然后按照体积比1:1加入食用陈醋混合得到最终制剂。
三、临床观察资料:
1、病例选择:
作为治疗尿结石的中药制剂,选择尿结石患者100例进行临床观察,病人随机分成两组,治疗组50例,其中男26例,女性24例,年龄28-65岁,平均年龄43.2岁,病程1-20个月,平均9.1个月;对照组50例,其中男性27例,女性23例,年龄27-64岁,平均年龄42.5岁,病程1-19个月,平均8.8个月。两组患者病情基本一致,无显著差异,具有可比性,两组均按要求控制饮食。
2、治疗组患者使用本发明中药制剂外敷腰部双肾部位,每日2次,每次1小时,7天为一疗程,连续敷用5到8个疗程,病情严重者遵医嘱酌增用量;对照组内服用市售的肾石通排石颗粒,按说明书服用。
3、疗效判断:
(1)治愈:B超显示结石粒排出或减小,腰痛、血尿、尿频、尿急、尿痛等泌尿系统梗阻和感染等临床症状减轻或消失。
(2)显效:B超现示结石粒有所减小,上述临床症状减轻。
(3)无效:B超现示结石粒无变化,上述临床症状未减轻。
4、治疗结果如下表:
以上结果显示,治疗组的总有效率明显高于对照组,且用本发明的中药制剂治愈率明显高于对照组。
5、典型病例举例:
1、陆某,男,56岁,退休工人,江西赣州人。半年前发病,身体左侧一直腰痛不止,吃药消炎止痛无效。经陆先生诉说得知,疼痛已经有8年时间,以前查出过肾结石,做了激光碎石治疗,中间6、7年没有出现疼痛,近1年疼痛次数比较频繁。临床诊断发现左肾结石,伴有轻度肾积水。外敷本发明中药制剂6个疗程后,已痊愈,B超检查左肾颗粒状结石消失,跟踪调查未见复发。
2、覃某,男,39岁,公务员,广西桂林人。无明显诱因出现腰疼痛,且呈间歇性绞痛。伴恶心、尿频症状,无呕吐、腹泻、尿痛、血尿、发热。临床诊断为双肾多发性结石。服用本发明中药制剂8个疗程,病情减轻,继续服用5个疗程,痊愈,B超检查显示无明显颗粒状结石,跟踪未见复发。
3、韦某,女,27岁,民企职工,广西柳州人。右侧腰部持续性胀痛,活动后,出现血尿并伴轻度尿急、尿频、尿痛。临床诊断为右肾颗粒型结石。服用本发明中药制剂6个疗程,结石消失,病情痊愈,跟踪未见复发。
4、付某,女,48岁,江西九江人。间歇发作性腹痛,伴有排尿中断和腰部剧烈胀痛,同时可伴血尿,诊断为临床上比较少见泥沙型结石;服用本发明中药制剂2个疗程,病情快速减轻,继续服用4个疗程,痊愈,跟踪未见复发。
Claims (6)
1.一种治疗肾结石的中药制剂,其特征在于:该中药制剂包括如下重量份的原料:
2.根据权利要求1所述的一种治疗肾结石的中药制剂,其特征在于该中药制剂包括如下重量份的原料:
3.根据权利要求1所述的一种治疗肾结石的中药制剂,其特征在于该中药制剂包括如下重量份的原料:
4.根据权利要求1-3中任一项所述的一种治疗肾结石的中药制剂的制备方法,其特征在于包括以下步骤:
(1)按重量份称取各种原料药;
(2)将黄柏、郁金、枳壳、甘草和木通一起切成2-5mm大小的碎粒,然后倒入50%vol白酒浸泡1-3小时,白酒的量以浸没倒入的药物为准,然后用水回流,每次加上以上所有药物重量2-5倍的水加热回流提取2-3次,每次提取1-3小时,过滤,合并滤液;
(3)取鸡内金研磨成粉末,金银花、连翘、金钱草、石韦、海金沙、鱼腥草、瞿麦和萹蓄切碎为长度小于1cm的颗粒,加入8-10倍量的食用陈醋溶液浸泡0.5-3小时,陈醋溶液为食用醋和纯净水按体积比1:1混合,用水回流,每次加上以上9味药重量2-5倍的水加热回流提取2-3次,每次提取1-3小时,过滤,合并滤液;
(4)将步骤(2)和步骤(3)中的滤液混合在一起再加入滑石,搅拌混匀,加热煮沸保持10-30分钟,过滤,滤液冷却至30-50℃,浓缩至室温测定相对密度为1.05-1.20的溶液,然后按照体积比1:1加入食用陈醋混合得到中药制剂。
5.根据权利要求4所述的一种治疗肾结石中药制剂的制备方法,其特征在于所述黄柏的制作方法为:取质量比为生黄柏1/10的食盐,用开水化开得食盐水,然后放进生黄柏,食盐水量以浸没生黄柏为准,浸泡0.5-2个小时,然后全部倒入干净的铁锅,待盐水蒸干后,用文火慢慢翻炒约10-15分钟,至颜色表面发黑,得到黄柏。
6.根据权利要求4所述的一种治疗肾结石中药制剂的制备方法,其特征在于所述鸡内金的制作方法为:将称量好的鸡内金放入温度为60-80℃烘箱中烘烤8-10小时,在冷冻干燥气体下冷至室温,粉碎为过50-100目筛的粉末。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610052829.5A CN105435135A (zh) | 2016-01-27 | 2016-01-27 | 一种治疗肾结石的中药制剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610052829.5A CN105435135A (zh) | 2016-01-27 | 2016-01-27 | 一种治疗肾结石的中药制剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105435135A true CN105435135A (zh) | 2016-03-30 |
Family
ID=55546058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610052829.5A Pending CN105435135A (zh) | 2016-01-27 | 2016-01-27 | 一种治疗肾结石的中药制剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105435135A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177766A (zh) * | 2016-08-11 | 2016-12-07 | 赵妙元 | 一种治疗肾结石的药包及其制作方法 |
| CN111450113A (zh) * | 2017-03-31 | 2020-07-28 | 柯昌贵 | 中草药敷脐化石胶囊 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101987187A (zh) * | 2009-07-31 | 2011-03-23 | 天津市公博科技开发有限公司 | 一种治疗结石病症的中草药配方 |
-
2016
- 2016-01-27 CN CN201610052829.5A patent/CN105435135A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101987187A (zh) * | 2009-07-31 | 2011-03-23 | 天津市公博科技开发有限公司 | 一种治疗结石病症的中草药配方 |
Non-Patent Citations (3)
| Title |
|---|
| CQ孙燕: "《http://www.yongyao.net/newshtml/0370080c-4d43-4695-8997-8bf72bad76d8.htm》", 27 September 2008 * |
| LZY1964041: "《http://www.doc88.com/p-8159916277106.html》", 7 March 2013 * |
| 邓飞: "肾结石中医药治疗进展", 《中国医药学报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177766A (zh) * | 2016-08-11 | 2016-12-07 | 赵妙元 | 一种治疗肾结石的药包及其制作方法 |
| CN111450113A (zh) * | 2017-03-31 | 2020-07-28 | 柯昌贵 | 中草药敷脐化石胶囊 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526616B (zh) | 一种治疗胆囊炎和胆结石的中草药丸 | |
| CN102000164B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
| CN100367985C (zh) | 一种消骨镇痛的中成药 | |
| CN102552576B (zh) | 一种治疗肾结石的中草药丸 | |
| CN103432485B (zh) | 一种治疗尿结石的中药制剂及制备方法 | |
| CN105435135A (zh) | 一种治疗肾结石的中药制剂及其制备方法 | |
| CN103893611B (zh) | 一种治疗肾结石的药物及制备方法 | |
| CN103735921B (zh) | 一种治疗尿道炎的药物及其制备方法 | |
| CN102805806B (zh) | 一种治疗痤疮美容养颜的药物及其制备方法 | |
| CN105288071A (zh) | 一种用于痔疮治疗及术后护理的中药组方及制备方法 | |
| CN106177766A (zh) | 一种治疗肾结石的药包及其制作方法 | |
| CN103877457B (zh) | 一种治疗肾结石的中药制剂及制备方法 | |
| CN107789525A (zh) | 一种治疗臁疮溃疡多年不愈的药物及其制备方法 | |
| CN102198261A (zh) | 一种治疗老年慢性结肠炎的中药制剂及其制备方法 | |
| CN100444871C (zh) | 治疗风湿、类风湿的全无毒中药组合物 | |
| CN105232849A (zh) | 一种治疗烧伤的膏药 | |
| CN103623111A (zh) | 一种治疗荨麻疹的中药 | |
| CN103908615A (zh) | 一种治疗外阴炎的中药药水及制备方法 | |
| CN105288433A (zh) | 一种用于放射性直肠炎治疗与护理的中药组方 | |
| CN104398829A (zh) | 具有美白养颜效果的治疗皮肤病的中药膏剂及其制备方法 | |
| CN104800685A (zh) | 一种治疗消化道感染的中药 | |
| CN105106590A (zh) | 一种用于治疗过敏性鼻炎的药物 | |
| CN104001082A (zh) | 一种治疗湿热郁滞型肾结石的中药 | |
| CN104435414A (zh) | 促进内痔手术伤口愈合的药液及其制备方法 | |
| CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160330 |